Svenungsson Bo, Burman Lars G, Jalakas-Pörnull Kirsti, Lagergren Asa, Struwe Johan, Akerlund Thomas
Division of Infectious Diseases, Department of Medicine, Karolinska Institute, Huddinge University Hospital, Huddinge, Stockholm, Sweden.
J Clin Microbiol. 2003 Sep;41(9):4031-7. doi: 10.1128/JCM.41.9.4031-4037.2003.
We prospectively studied the epidemiology of Clostridium difficile-associated diarrhea (CDAD) in a 900-bed hospital over the course of 12 months by PCR-ribotyping of C. difficile isolates. A total of 304 cases were diagnosed, corresponding to an overall incidence of 7/1,000 admissions, with higher rates in nephrology, hematology, and organ transplantation wards (37, 30, and 21/1,000), and 72% were classified as hospital associated (onset in hospital or onset at home but after a hospital stay within 2 months). All 382 isolates from 227 of 304 (75%) patients available for PCR-ribotyping were typeable, yielding 70 PCR-ribotypes. The three most common types comprised 30% of hospital-associated and 34% of community-associated cases, indicating import via admitted patients as a major source of C. difficile strains occurring in the hospital. Of the 227 patients studied, 38% each contributed 2 to 13 fecal samples positive for C. difficile over the course of the study period. Repeat isolates of the same PCR-ribotype as the first isolate were found in 79% of these patients and in 95% of specimens delivered within 30 days, compared to 63% of those obtained at 31 to 204 days. Nosocomial acquisition of CDAD, defined as the proportion of cases sharing C. difficile type and admitted to the same ward within 2 or 12 months, was 20% and 32% of hospital-associated cases and 14% and 23% of all cases, respectively. Thus, most CDAD cases diagnosed over the course of the study period, including those associated with hospitalization, appeared to be caused by endogenous C. difficile strains rather than by strains truly being acquired in the hospital.
我们在一家拥有900张床位的医院,通过对艰难梭菌分离株进行PCR核糖体分型,对艰难梭菌相关性腹泻(CDAD)的流行病学情况进行了为期12个月的前瞻性研究。共诊断出304例病例,总体发病率为每1000例入院患者中有7例,肾病科、血液科和器官移植病房的发病率更高(分别为每1000例中有37例、30例和21例),72%的病例被归类为医院相关性(在医院发病或在家发病但在住院后2个月内)。304例患者中的227例(75%)可用于PCR核糖体分型,其382株分离株均能分型,产生了70种PCR核糖体分型。三种最常见的分型占医院相关性病例的30%和社区相关性病例的34%,表明通过入院患者带入是医院中艰难梭菌菌株的主要来源。在研究的227例患者中,38%的患者在研究期间提供了2至13份艰难梭菌粪便阳性样本。在这些患者中,79%的患者再次分离出与首次分离株相同PCR核糖体分型的菌株,在30天内送检的标本中这一比例为95%,而在31至204天获得的标本中这一比例为63%。医院获得性CDAD定义为在2个月或12个月内艰难梭菌分型相同且入住同一病房的病例比例,分别占医院相关性病例的20%和32%,占所有病例的14%和23%。因此,在研究期间诊断出的大多数CDAD病例,包括与住院相关的病例,似乎是由内源性艰难梭菌菌株引起的,而非真正在医院获得的菌株。